JohnFrancisMcDyerMD

Interstitial Lung Diseases, Lung Transplantation Medicine

Scientific Director, University of Pittsburgh Lung Transplant Research Center

Dr. McDyer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3459 Fifth Avenue, NW 628
Pittsburgh, PA 15213
Phone+1 412-624-8915

Fax+1 412-692-2260

Dr. John McDyer is a transplant pulmonologist in Pittsburgh, PA and is affiliated with multiple hospitals in the area, including UPMC Presbyterian Shadyside and UPMC Children's Hospital of Pittsburgh. He is a Professor and tenured physician scientist at the University of Pittsburgh School of Medicine. He received his medical degree from Sidney Kimmel Medical College at Thomas Jefferson University and has been in practice 27 years. He specializes in interstitial lung diseases and lung transplantation medicine and is experienced in lung transplantation, cytomegalovirus, bronchiolitis obliterans, flow cytometry, and genetics of interstitial lung disease with an emphasis in telomere biology. He has more than 100 publications and over 500 citings.

Johns Hopkins University School of MedicineFellowship, Joint Critical Care/Pulmonary Medicine, 1998 - 2002
National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1993 - 1998
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1990 - 1993
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1990
St. Joseph's UniversityB.S., Chemistry , 1982 - 1986

PubMed

47 citations
A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.
Yanwen Chen, Travis Lear, John Evankovich, Mads Breum Larsen, Bo Lin
Nature Communications. 2021-06-23
24 citations
Contemporary trends in PGD incidence, outcomes, and therapies.
Edward Cantu, Joshua M Diamond, Marisa Cevasco, Yoshi Suzuki, Maria Crespo
The Journal of Heart and Lung Transplantation. 2022-12-01
9 citations
SARS-CoV-2 Accessory Protein Orf7b Induces Lung Injury via c-Myc Mediated Apoptosis and Ferroptosis.
Rushikesh Deshpande, Wangyang Li, Tiao Li, Kristen V Fanning, Zachary Clemens
International Journal of Molecular Sciences. 2024-01-18

‘An Emergency Need’: Doctors Issue Call for Help to Fight Shrinking Supply of Convalescent PlasmaJanuary 18th, 2021
Common Drug May Prevent Afib After Lung TransplantMay 24th, 2019

Development Of Cmv-Specific T Cell Memory In Lung Transplant RecipientsNational Institute Of Allergy And Infectious Diseases2011
Development Of Cmv-Specific T Cell Memory In Lung Transplant RecipientsNational Institute Of Allergy And Infectious Diseases2009–2011
CMV Replication During Primary Infection In Lung Transplant RecipientsNational Institute Of Allergy And Infectious Diseases2008–2009
Cmv-Specific T-Cell Immunity In Lung Transplant RecipientsNational Institute Of Allergy And Infectious Diseases2007–2008
Regulation Of TH1 Responses By IL-2 Receptor BlockadeNational Heart, Lung, And Blood Institute2003–2007